v3.25.3
NOTE 6: STOCKHOLDERS' DEFICIT: Schedule of Stockholders' Equity Note, Warrants or Rights (Tables)
9 Months Ended
Sep. 30, 2025
Tables/Schedules  
Schedule of Stockholders' Equity Note, Warrants or Rights

The following summarizes the Company’s warrant activity for the nine months ended September 30, 2025:

 

 

 

 

 

 

Weighted-Average

 

 

 

 

 

Remaining

 

 

 

Weighted
Average

 

Contractual
Life

 

Warrants

 

Exercise Price

 

(Years)

Outstanding at December 31, 2024

1,198,850 

 

$4.15 

 

3.18 

Granted

- 

 

- 

 

- 

Forfeited

- 

 

- 

 

- 

Outstanding at September 30, 2025

1,198,850 

 

$4.15 

 

2.43 

 

 

 

 

 

 

 

 

 

 

 

 

Vested and expected to vest at September 30, 2025

1,198,850 

 

$4.15 

 

2.43 

Exercisable at September 30, 2025

1,198,850 

 

$4.15 

 

2.43